PortfoliosLab logoPortfoliosLab logo
PJP vs. SPAQ
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

PJP vs. SPAQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco Dynamic Pharmaceuticals ETF (PJP) and Horizon Kinetics SPAC Active ETF (SPAQ). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

PJP vs. SPAQ - Yearly Performance Comparison


2026 (YTD)202520242023
PJP
Invesco Dynamic Pharmaceuticals ETF
-0.44%27.98%9.63%-1.12%
SPAQ
Horizon Kinetics SPAC Active ETF
0.06%7.35%4.33%5.52%

Returns By Period

In the year-to-date period, PJP achieves a -0.44% return, which is significantly lower than SPAQ's 0.06% return.


PJP

1D
3.04%
1M
-3.96%
YTD
-0.44%
6M
12.79%
1Y
21.16%
3Y*
12.12%
5Y*
6.67%
10Y*
6.42%

SPAQ

1D
0.62%
1M
-0.24%
YTD
0.06%
6M
1.51%
1Y
4.82%
3Y*
5.22%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


PJP vs. SPAQ - Expense Ratio Comparison

PJP has a 0.58% expense ratio, which is lower than SPAQ's 0.85% expense ratio.


Return for Risk

PJP vs. SPAQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PJP
PJP Risk / Return Rank: 6262
Overall Rank
PJP Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
PJP Sortino Ratio Rank: 6464
Sortino Ratio Rank
PJP Omega Ratio Rank: 5757
Omega Ratio Rank
PJP Calmar Ratio Rank: 7171
Calmar Ratio Rank
PJP Martin Ratio Rank: 5454
Martin Ratio Rank

SPAQ
SPAQ Risk / Return Rank: 3434
Overall Rank
SPAQ Sharpe Ratio Rank: 3030
Sharpe Ratio Rank
SPAQ Sortino Ratio Rank: 2929
Sortino Ratio Rank
SPAQ Omega Ratio Rank: 3131
Omega Ratio Rank
SPAQ Calmar Ratio Rank: 3838
Calmar Ratio Rank
SPAQ Martin Ratio Rank: 3939
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PJP vs. SPAQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Pharmaceuticals ETF (PJP) and Horizon Kinetics SPAC Active ETF (SPAQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PJPSPAQDifference

Sharpe ratio

Return per unit of total volatility

1.12

0.56

+0.56

Sortino ratio

Return per unit of downside risk

1.58

0.84

+0.74

Omega ratio

Gain probability vs. loss probability

1.20

1.13

+0.07

Calmar ratio

Return relative to maximum drawdown

1.77

0.98

+0.79

Martin ratio

Return relative to average drawdown

5.03

3.66

+1.37

PJP vs. SPAQ - Sharpe Ratio Comparison

The current PJP Sharpe Ratio is 1.12, which is higher than the SPAQ Sharpe Ratio of 0.56. The chart below compares the historical Sharpe Ratios of PJP and SPAQ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


PJPSPAQDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.12

0.56

+0.56

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.42

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.35

Sharpe Ratio (All Time)

Calculated using the full available price history

0.59

0.78

-0.19

Correlation

The correlation between PJP and SPAQ is 0.07, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

PJP vs. SPAQ - Dividend Comparison

PJP's dividend yield for the trailing twelve months is around 1.02%, less than SPAQ's 16.68% yield.


TTM20252024202320222021202020192018201720162015
PJP
Invesco Dynamic Pharmaceuticals ETF
1.02%0.98%0.97%1.01%0.95%0.81%0.75%0.77%1.12%0.65%0.91%5.49%
SPAQ
Horizon Kinetics SPAC Active ETF
16.68%16.69%3.00%2.60%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

PJP vs. SPAQ - Drawdown Comparison

The maximum PJP drawdown since its inception was -37.06%, which is greater than SPAQ's maximum drawdown of -5.30%. Use the drawdown chart below to compare losses from any high point for PJP and SPAQ.


Loading graphics...

Drawdown Indicators


PJPSPAQDifference

Max Drawdown

Largest peak-to-trough decline

-37.06%

-5.30%

-31.76%

Max Drawdown (1Y)

Largest decline over 1 year

-11.68%

-5.30%

-6.38%

Max Drawdown (5Y)

Largest decline over 5 years

-17.51%

Max Drawdown (10Y)

Largest decline over 10 years

-33.95%

Current Drawdown

Current decline from peak

-5.83%

-1.97%

-3.86%

Average Drawdown

Average peak-to-trough decline

-8.90%

-0.53%

-8.37%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.88%

1.41%

+3.47%

Volatility

PJP vs. SPAQ - Volatility Comparison

Invesco Dynamic Pharmaceuticals ETF (PJP) has a higher volatility of 6.62% compared to Horizon Kinetics SPAC Active ETF (SPAQ) at 1.75%. This indicates that PJP's price experiences larger fluctuations and is considered to be riskier than SPAQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


PJPSPAQDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.62%

1.75%

+4.87%

Volatility (6M)

Calculated over the trailing 6-month period

11.57%

6.25%

+5.32%

Volatility (1Y)

Calculated over the trailing 1-year period

19.11%

8.60%

+10.51%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

15.97%

7.04%

+8.93%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.42%

7.04%

+11.38%